According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.89. In 2022 the company made an earnings per share (EPS) of -$2.75 a decrease over its 2021 EPS that were of -$2.18.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.89 | 5.09% |
2022 | -$2.75 | 26.25% |
2021 | -$2.18 | 99.58% |
2020 | -$1.09 |